Mark S. MD Gelder is CHIEF MEDICAL OFFICER of Traws Pharma Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Onconova Therapeutics, Inc.
14 Mar 23
4
Onconova Therapeutics, Inc.
8 Feb 23
4
Onconova Therapeutics, Inc.
4 Aug 22
4
Onconova Therapeutics, Inc.
9 Feb 22
4
Onconova Therapeutics, Inc.
29 Sep 21
4
Onconova Therapeutics, Inc.
4 Aug 21
4
Onconova Therapeutics, Inc.
17 Jun 21
3
Onconova Therapeutics, Inc.
17 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Mar 23 | TRAW Traws Pharma | RSU Common Stock | Grant | Acquire A | No | No | 0 | 20,667 | 0.00 | 20,667 |
13 Mar 23 | TRAW Traws Pharma | Stock Option (right to purchase) Common Stock | Grant | Acquire A | No | No | 0.73 | 62,000 | 45.26 k | 62,000 |
7 Feb 23 | TRAW Traws Pharma | Common Stock | Payment of exercise | Dispose F | No | No | 1.36 | 1,242 | 1.69 k | 10,487 |
7 Feb 23 | TRAW Traws Pharma | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,833 | 0.00 | 11,729 |
7 Feb 23 | TRAW Traws Pharma | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 5,833 | 0.00 | 11,667 |